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Introduction
A hallmark and critical determinant of the pathogene-
sis of the lentivirus subfamily of retroviruses is the ability 
to infect non-dividing cells. After reverse transcription, tar-
geting of the viral DNA to the nucleus of cells is mediated 
by a large nucleoprotein preintegration complex (PIC). 
This complex, which has been difficult to characterize, is 
comprised of both cellular and viral components. Likely, 
only a small number of the cellular proteins associated 
with the PIC have been identified. Among those identi-
fied, only a few, including barrier to auto integration factor 
(BAF) and HMG Y(I), have been shown to be functionally 
relevant (Chen and Engelman, 1998, Farnet and Bushman, 
1997, Harris and Engelman, 2000, Hindmarsh et al., 1999, 
Li et al., 2000, and Lin and Engelman, 2003). The viral com-
ponents include the dsDNA, reverse transcriptase, matrix, 
nucleocapsid, integrase, and Vpr (HIV-1) or Vpx (HIV-
2/SIV) proteins (Bukrinsky et al., 1993, Farnet and Hasel-
tine, 1991, Hansen and Bushman, 1997, Karageorgos et al., 
1993, and Miller et al., 1997). HIV-2 contains both the vpr 
and vpx genes, each with discrete functions (Fletcher et al., 
1996). While Vpx is homologous to HIV-1 Vpr, is pack-
aged into virions, and is a component of the HIV-2 PIC, it 
lacks a nuclear export signal and any cell-cycle arrest func-
tion (Belshan and Ratner, 2003 and Hansen and Bushman, 
1997). Therefore, like HIV-1 Vpr, Vpx is necessary for ef-
fective nuclear translocation of the PIC, but is dispensable 
for integration. Furthermore, SIVsm Vpx has been demon-
strated to be required for efficient virus dissemination and 
pathogenesis in vivo (Hirsch et al., 1998).
In addition to its composition, the transport of the PIC 
remains one of the least well understood aspects of HIV 
replication. Work by McDonald et al. suggests that the PIC 
associates with and traverses the microtubule network to 
microtubule organizing centers near the nuclear envelope 
(McDonald et al., 2002). However, it remains unclear what 
facilitates PIC transport along the network. Furthermore, 
once the PIC reaches the nuclear membrane, the sequence 
of events that result in the nuclear import of the viral ds-
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Abstract
The HIV-2 viral accessory protein Vpx is related to, but distinct from the Vpr protein of HIV-1. Vpx is packaged into virions and 
as a component of the viral preintegration complex (PIC) is required for efficient virus replication in non-dividing cells. We have 
previously reported that the minimal transferable region of Vpx that contained karyophilic properties was aa 65 to 72. Analysis of 
Vpx sequences from various HIV-2/SIV strains reveals that this region contains highly conserved amino acids, including two ba-
sic residues (K68, R70) and three tyrosines (Y66, Y69, Y71). Here, we demonstrate that mutation of the basic or tyrosine residues 
abolishes PIC nuclear import in arrested cells as assessed by PCR detection of viral integration. Examination of cell-free virus by 
Western blot indicated that all mutant proteins were incorporated into virions, suggesting that the lack of replication in arrested 
cells was not due to a loss of Vpx in target cells. Together, these studies map critical residues of the Vpx nuclear localization signal 
that are required for efficient infection of non-dividing cells.
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DNA remains unclear. Numerous viral components of the 
HIV-1 PIC contain one or more karyophilic signals includ-
ing matrix, integrase, vDNA (central polypurine tract), and 
Vpr (or Vpx for HIV-2/SIV) (reviewed in Goff, 2001, Sher-
man and Greene, 2002, and Stevenson, 1996). However, de-
letion of any single signal results in only a modest reduc-
tion of PIC import efficiency. Therefore, these signals do 
not appear to be synergistic, but rather redundant.
HIV-2 Vpx is a small hydrophobic protein that is a com-
ponent of the PIC and required for efficient infection of non-
dividing cells (Mahalingam et al., 2001, Pancio et al., 2000, 
and Ueno et al., 2003). The localization of Vpx is context de-
pendent. Vpx has a nuclear localization signal (NLS), but 
no NES (Belshan and Ratner, 2003). In the presence of un-
processed Gag in a virus producing cell, Vpx is packaged 
into virions through an interaction with the p6 region of 
Gag (Jin et al., 2001, Pancio and Ratner, 1998, and Selig et 
al., 1999). Packaging of Vpx is necessary for its activity dur-
ing the early stage of virus replication. Expressed in the ab-
sence of the Gag polyprotein, Vpx predominantly localizes 
to the nuclei of cells (Belshan and Ratner, 2003, Mahalingam 
et al., 2001, and Pancio et al., 2000). We have mapped a min-
imal transferable nuclear localization signal (NLS) to amino 
acids 65–72 (Belshan and Ratner, 2003); however, other C-
terminal residues have been implicated in regulating Vpx 
nuclear localization and PIC import in non-dividing cells 
(Belshan and Ratner, 2003, Pancio et al., 2000, and Rajen-
dra Kumar et al., 2003). In these studies, there exists a strong 
correlation between the ability of Vpx mutants to localize to 
the nucleus and the ability of viruses containing those mu-
tations to infect non-dividing cells. Thus, Vpx appears to be 
a critical regulator of HIV-2/SIV PIC nuclear import.
The goal of our ongoing studies is to characterize the 
pathway of Vpx nuclear import as a means to dissect the 
process of PIC transport and nuclear targeting. We have ex-
amined the minimal transferable nuclear localization signal 
of HIV-2 Vpx (…65SYTKYRYL72…). This stretch of amino 
acids is highly conserved among HIV-2/SIV strains (Figure 
1A), further suggestive evidence of the importance of this 
region. Here, we use mutational analysis to study the Vpx 
NLS and characterize the role of Vpx in PIC nuclear trans-
port. We define three critical residues (K68, Y69, R70) in the 
minimal transferable NLS required for HIV-2 infection of 
non-dividing cells. Mutation of any of these residues did 
not appear to inhibit Vpx incorporation into virions, sug-
gesting that the NLS is separable from the packaging do-
main of Vpx. Nor did these mutations impede HIV-2 infec-
tion of dividing cells. Thus, we have defined several critical 
cis-acting residues of the Vpx NLS for targeting of the HIV-
2 PIC in non-dividing cells.
Results
Mutagenesis of conserved amino acids in the Vpx nuclear local-
ization signal (NLS)
Our previous studies identified two transferable NLSs 
of Vpx that overlapped at amino acids 65–72 (Belshan and 
Ratner, 2003). Our next goal was to identify the critical resi-
dues of Vpx to further characterize the pathway of Vpx nu-
clear import and the role of Vpx in preintegration complex 
(PIC) nuclear targeting. Examination of various HIV-2 and 
SIV Vpx sequences in the Los Alamos Database indicated 
that several amino acids within this region are highly con-
served among the HIV-2/SIV family (Figure 1A), suggest-
ing they are essential for the function of the protein. In our 
previous study, we noted that alanine substitution of both 
basic residues (K68 and R70) and/or the three tyrosine resi-
dues (Y66, Y69, Y71), but not the serine residues ablated the 
nuclear localization of a green fluorescent protein-Vpx fu-
sion protein (Belshan and Ratner, 2003). In the present stud-
ies, we wished to determine the effect of these substitutions 
in Vpx on PIC import. Therefore, we constructed a series of 
full length HIV-2 ROD10 molecular clones containing these 
original alanine substitutions in Vpx and also constructed 
additional Vpx mutants with different combinations of ala-
nine substitutions for the tyrosine residues (Figure 1B).
Infection of MAGI-5 cells with viruses containing alanine sub-
stitutions in the Vpx NLS
It has been known for some time that Vpx is dispens-
able for replication in dividing cells in vitro (Hu et al., 1989, 
Kappes et al., 1991, Marcon et al., 1991, Shibata et al., 1990, 
and Yu et al., 1991). To confirm that the molecular  clones we
Figure 1. Conservation of the Vpx NLS and mutants con-
structed for these studies. (A) Alignment of selected sequences 
from the Los Alamos HIV sequence database. The consensus 
sequence is given at the top. Capital letters indicate highly 
conserved amino acid residues, small-case letters denote dom-
inant amino acid residues, ‘x’ indicates no dominant residue. 
(B) Summary of the mutations constructed for the studies pre-
sented. RMX-Δ represents a clone in which both methionine 
codons of vpx have been altered to abolish protein translation.
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constructed were viable, we assayed the ability of each vi-
rus to infect MAGI-5 indicator cells. Viruses were produced 
by transfection of 293T cells, concentrated, and quanti-
fied by p27 ELISA. MAGI-5 cells were infected in 96-well 
plates with equal amounts of virus (usually 5 ng/well) for 
48 h, then fixed and stained for β-galactosidase expression. 
The virus titer was calculated by the number of blue nu-
clei. As expected, all viruses, including the vpx-deleted vi-
rus (RMX-delta) retained the ability to infect dividing cells 
(Figure 2). With the exception of the triple tyrosine to al-
anine mutant (RMX-Y-A), all the viruses infected the cells 
at levels similar to the wild-type ROD10. RMX-Y-A consis-
tently displayed approximately 70% of the level of infec-
tion of the wild-type ROD10.
Amino acids 68–70 of Vpx are critical for HIV-2 infection of 
non-dividing cells
Our previous studies demonstrated that mutation of the 
basic and tyrosine residues disrupted the ability of GFP-
Vpx to localize to the nucleus of cells (Belshan and Ratner, 
2003). Next, we wanted to determine the effects of these 
substitutions on the ability of HIV-2 to infect non-dividing 
cells. Given the large number of mutants we needed to as-
say, we developed a short-term arrested-cell assay rather 
than utilize the traditional Mf infection assays. Adapted 
from the method described by Brussel and Sonigo (2003), 
this assay detects integrated viral DNA by nested PCR (see 
Materials and methods). For each experiment, U937 cells 
were synchronized by serum starvation for 48 h and half of 
the cells arrested by release into complete medium contain-
ing 400 μM l-mimosine. The other half was released into 
complete medium as a dividing cell control. Growth-arrest 
of the cells was monitored by propidium iodine staining at 
the end of the experiment (data not shown). Genomic DNA 
was isolated at 0, 24, and 48 h post-infection to assess vi-
ral DNA integration by nested PCR. The first PCR uses two 
Alu element primers and an HIV-2 LTR-specific primer 
with a linker. This PCR amplifies LTR-genome fragments of 
various sizes. The second PCR uses the linker primer with 
another HIV-2 LTR primer and amplifies a specific product 
of 242 bp. The second PCR was performed with [32P]TTP 
for visualization of the product by autoradiography after 
electrophoresis. Genomic DNA from a known number of 
CEMx174 cells chronically infected with HIV-2ST (Kong et 
al., 1988) was used as a positive control in each experiment 
(data not shown). Each mutant virus was assayed at least 
three times and the results presented in Figure 3 represent 
the dominant phenotype observed for each viral mutant.
Each individual experiment contained both ROD10 and 
the vpx-deleted virus, RMX-Δ. As indicated, ROD10 in-
fected the arrested U937 cells only slightly less well than 
the dividing cells (Figure 3). RMX-Δ repeatedly failed to ef-
ficiently infect the arrested U937 cells, but still infected the 
dividing cells. Therefore, RMX-Δ acted as a negative con-
trol in each experiment. Additional controls assayed but 
not shown included uninfected cells and cells infected with 
heat-inactivated (65 °C for 30 min) ROD10. Integrated virus 
was not detected in either of these cells after repeat exper-
iments. Alanine substitution of serine residues 65 and 67 
(RMX-S-A) appeared to have no effect on the ability of the 
virus to infect non-dividing cells. However, alanine sub-
stitution of the three tyrosine residues at positions 66, 69, 
and 71 (RMX-Y-A) or both basic residues (K68, R70-RMX-
KR) abolished infection of the growth-arrested cells. Inter-
estingly, these results correlate well with the cell localiza-
tion phenotypes we previously observed with mutations in 
GFP-Vpx (Belshan and Ratner, 2003).
The conservation and critical requirement of these tyro-
sine residues for nuclear localization made it tempting to 
speculate that phosphorylation of these residues could reg-
ulate Vpx function. Although initial studies reported that 
HIV-2 Vpx was not phosphorylated (Franchini et al., 1988), 
a recent study demonstrated phosphorylation of SIV Vpx 
(Rajendra Kumar et al., 2005). However, our own analysis 
by [32P]phosphoric acid labeling of either virus or over-ex-
pressed Vpx failed to detect any phosphorylation (data not 
shown). Furthermore, to assay whether any such modifica-
tion to the tyrosine residues was important for PIC import, 
we constructed a clone in which we substituted phenylal-
anine at the three tyrosine positions (RMX-Y-F). This vi-
rus retained the ability to infect non-dividing cells (Figure 
3). These two pieces of evidence suggest that phosphory-
lation at these tyrosine residues does not regulate HIV-
2 Vpx function. Further mutation of the tyrosine residues 
indicated that Tyr69 alone is critical for the ability of Vpx 
to mediate infection of non-dividing cells. This is demon-
strated by the fact that any clone containing the Y69A sub-
stitution (RMX-66,69A, RMX-69,71A, RMX-69A) was un-
able to efficiently infect growth-arrested cells. Together, the 
results from this series of experiments indicate that amino 
acids 68–70 of HIV-2 Vpx are critical for the infection of 
non-dividing cells.
We also determined the cell localization phenotype of 
GFP-Vpx fusion proteins containing the tyrosine to ala-
Figure 2. Infection of MAGI-5 cells by viruses containing mu-
tations in Vpx. MAGI-5 cells were infected and virus titer de-
termined as described in Materials and methods. Results are 
presented as a comparison to the wild-type ROD10 virus and 
represent at least three independent experiments with at least 
triplicate infections. Bars denote standard error of the mean.
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nine substitutions. Similar to the pattern of results we pre-
viously observed, the fusion proteins containing the three 
tyrosine to alanine substitutions (GFP-X-Y-A) or the Y69A 
mutation alone (GFP-X-Y69A) displayed a loss of nuclear 
accumulation compared to the wild-type GFP-Vpx fusion 
protein (GFP-X) (Figure 4). The other constructs contain-
ing the Y69A substitution (Y66,69A and Y69,71A) also lost 
nuclear accumulation (data not shown). Collectively, these 
and our previous localization results (Belshan and Rat-
ner, 2003) demonstrate that amino acids 68–70 are critical 
for nuclear localization of Vpx in addition to the ability of 
HIV-2 to infect non-dividing cells.
The inability of Vpx NLS mutants to infect non-dividing cells 
does not result from a loss of virion associated protein
Vpx is dispensable for replication in dividing, but not 
non-dividing cells. To confirm that the defective pheno-
types observed in the non-dividing cell infection assay did 
not result from an absence of Vpx in the virions and subse-
Figure 3. Ability of vpx-NLS mutant viruses to infect arrested and dividing U937 cells. U937 cells were growth arrested and in-
fected as described in Materials and methods. Cells were infected with viruses containing the indicated mutations in vpx. At the 
times noted, genomic DNA was harvested and the integration of viral DNA detected by the nested PCR method described in the 
Materials and methods. Each mutant was assayed at least three times and the panel presented for each mutant represents the 
dominant phenotype. Control PCR assays for the detection of β-globin indicated similar levels of genomic DNA (±10%) were iso-
lated among the samples (data not shown).
Figure 4. Alanine substitution of Tyrosine 69 in the Vpx NLS abolishes nuclear accumulation of GFP-Vpx. HeLa cells were tran-
siently transfected with the indicated GFP-Vpx fusion protein constructs. 24 h later, the cells were fixed, permeabilized, stained 
with DAPI (lower panels), and imaged with a fluorescence microscope.
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quent PICs, we examined whether the mutant viruses ob-
served to be incompetent to infect non-dividing cells incor-
porated the mutant Vpx proteins into virions. Virus was 
produced by transient transfection of 293T cells. 48 h post-
transfection, both the supernatants and cell lysates were 
harvested. Virus in the supernatants was concentrated by 
ultracentrifugation through a 20% sucrose cushion (w/v in 
PBS). Vpx and p27 were detected on separate blots using 
monoclonal antibodies (Figure 5). Vpx was detected in all 
the mutants except for the vpx-deleted mutant, RMX-Δ, in-
dicating that none of the substitutions were deleterious for 
Vpx incorporation into virions. The results were not sur-
prising as previous studies indicate that the determinants 
of HIV-2 Vpx packaging map to amino acids 74–86 (Jin et 
al., 2001). These results indicate that the failure of the vi-
ruses containing the basic or tyrosine mutations to infect 
non-dividing cells is not due to an absence of Vpx in the in-
coming virus particles.
Discussion
HIV-2 Vpx is thought to have arisen as a gene duplica-
tion of Vpr, and similar to HIV-1 Vpr Vpx is required for 
efficient PIC nuclear import of non-dividing cells (Fletcher 
et al., 1996, Sharp et al., 1996, Tristem et al., 1990, and 
Tristem et al., 1998). Indeed, Vpx and Vpr sequences com-
prise a Protein Family (Pfam) domain (PF00522) in their 
central regions (aa 5–99) (Bateman et al., 2004), suggest-
ing likely structural and functional conservation among 
these proteins. Therefore, it has been proposed that Vpx 
uses a method of nuclear import similar to Vpr. Since Vpr 
has been shown to interact with importin α (Kamata et al., 
2005, Popov et al., 1998b, and Vodicka et al., 1998) and other 
nucleoporins (Popov et al., 1998a and Vodicka et al., 1998), 
it is likely that Vpr enters the nucleus via the nuclear pore. 
Because of their similarities, we initially hypothesized that 
Vpx likely utilizes a similar method of nuclear entry as Vpr. 
While still a viable hypothesis, several findings suggest that 
Vpr may not be a model system for Vpx. We have identified 
amino acids 65–72 as a minimal NLS of HIV-2 Vpx, and a 
larger domain was confirmed to contain an NLS by Kumar 
et al. (Belshan and Ratner, 2003 and Rajendra Kumar et al., 
2003). Further confirmation of the role of this Vpx domain 
in nuclear import would involve studies of the effect of mu-
tations described here on HIV-2 replication in macrophages. 
However, the parental virus used in this study, ROD-10, rep-
licates inefficiently in macrophages (data not shown). Thus, 
transfer of these mutations to a different HIV-2/SIV proviral 
clone will be required for these future studies.
There are two points of interest concerning this region of 
Vpx. First, this region is not homologous to the Vpr NLS and 
lacks any recognizable classical NLS. Second, although this 
region is highly conserved among numerous HIV-2/SIV iso-
lates and Vpx and Vpr constitute a Pfam, a predicted struc-
tural alignment of Vpx with HIV-1 Vpr the region of Vpx 
containing the NLS (aa 65–72) shows weak conservation rel-
ative to the highly conserved core domain spanning aa 23–
87. The smaller region is predicted to loop out relative to the 
three helix structure in Vpr (Figure 6). Together, this dem-
onstrates the significance of the NLS region of Vpx, but sug-
gests that the function(s) associated with this region is dis-
tinct from Vpr. Furthermore, several homology queries of 
this region with internet databases yielded no matches. 
These data support the possibility that Vpx utilizes a unique 
method of nuclear import, dissimilar to that of Vpr. Indeed, 
we have performed several yeast two-hybrid screens with 
Vpx in attempt to identify the pathway Vpx interacts with 
to access the nucleus. In addition, we also assayed Vpx with 
a battery of nuclear pore proteins and importins using the 
yeast system. While our attempts have yielded no positive 
interactions (data not shown), they highlight the differences 
between HIV-1 Vpr and Vpx and suggest a novel method of 
nuclear transport for Vpx.
Numerous mutations in the Vpx C-terminus have been 
identified that disrupt infection of non-dividing cells. A 
loss of Vpx function in PIC nuclear targeting may result 
from several factors, including, but not limited to either a 
block of Vpx incorporation into virions, a disruption of PIC 
nuclear import, abolishment of Vpx association with the 
PIC, or a loss of interaction with an unknown cellular fac-
tor required for PIC import. Interestingly, to date, all of the 
mutations in Vpx that disrupt PIC nuclear import or infec-
tion of non-dividing cells have been shown to be nuclear 
localization defective. This strong correlation suggests that 
the critical function of Vpx in PIC nuclear transport is nu-
clear localization. However, there still remains the question 
of the importance of other residues in the C-terminus of 
Vpx. Amino acids identified as critical for Vpx nuclear im-
port and HIV-2/SIV infection of non-dividing cells include 
residues within and without the characterized NLS, such as 
aa 74–80, H82, G86, C87, and the proline-rich region (101–
109) (Belshan and Ratner, 2003, Mahalingam et al., 2001, 
and Pancio et al., 2000). Any of these mutations may del-
Figure 5. Incorporation of mutant Vpx proteins into virions. 
Virus was produced by transient transfection of 293T cells and 
virus collected for 48 h. After the final collection, the cell ly-
sates were harvested, then the supernatants precleared and 
the virus concentrated by ultracentrifugation through a 20% 
sucrose cushion. Proteins were separated by SDS-PAGE and 
Vpx and the p27 capsid proteins detected using specific anti-
bodies as indicated.
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eteriously affect Vpx structure, Vpx association with the 
PIC, or the interaction of Vpx with a yet-to-be identified 
cellular factor. Indeed, none of the Vpx mutants that dis-
rupt PIC nuclear import have been examined for their abil-
ity to associate with the PIC. Further structure/function 
studies must be undertaken to delineate the role of these 
residues in PIC nuclear transport. We observed one result 
that directly contrasts another report indicating that triple 
tyrosine to alanine mutation in SIV Vpx ablates virion in-
corporation but has no effect on nuclear localization of Vpx 
(Mahalingam et al., 2001). It is presently unclear to us why 
we observe a contradictory phenotype, but this may be the 
result of disparate methods or differences between HIV-2 
and SIV packaging of Vpx. Further studies are required to 
delineate the observed differences.
The Vpr/Vpx proteins are considered an important com-
ponent of the karyophilic signal of the HIV preintegration 
complex (PIC). The current data suggest that loss of HIV-
2/SIV Vpx is more deleterious than the loss of HIV-1 Vpr 
(Connor et al., 1995, Haffar et al., 2000, Heinzinger et al., 1994, 
Mahalingam et al., 2001, Pancio et al., 2000, Ueno et al., 2003, 
and Yu et al., 1991); however, additional and more sensitive 
assays with HIV-2/SIV need to be performed to bolster this 
conclusion. Similarly, it has been demonstrated in vivo that 
deletion of Vpx reduces virus dissemination and productive 
infection in pigtailed macaques (Hirsch et al., 1998). Combi-
nation of the in vitro and in vivo data supports the idea that 
Vpx is a critical karyophilic component of the HIV-2/SIV 
PIC. However, it should be noted that neither integrase and 
MA NLS mutants, nor cPPT mutants have yet to be assessed 
for SIV in vivo. Such studies would likely clarify the in vivo 
contribution of each putative karyophilic signal and further 
our understanding of PIC nuclear targeting.
Materials and methods
Molecular clone construction and virus production and analysis
ROD10 was a kind gift of Klaus Strebel (Bour et al., 1996). 
Mutagenesis of vpx was performed using a shuttling vector 
containing a modified SacI–SacI fragment (nt 5284–5876) of 
ROD10 in pGEM-T (Promega, Madison, WI). The modifica-
tion removed the naturally occurring SacI restriction site at 
nt 5700. This was accomplished by PCR overlap extension 
mutagenesis and did not alter the vpr ORF. The final plas-
mid (pX-CC) was used to construct the series of mutations 
in vpx by overlap extension PCR. Mutagenesis was con-
firmed by sequencing and then the fragment was digested 
and ligated into the parental pROD10. The final clones were 
also confirmed by sequencing. The sequences of all primers 
were designed from the Genbank sequence of ROD10 (ac-
cession # X05291). The sequence of these oligos and those 
used for the mutagenesis are available upon request.
Virus stocks were produced by transient transfection of 
293T cells. 1 × 106 293T cells were seeded in 10 cm2 plates. 
24 h later, the media were changed and the cells were trans-
fected with 20 μg of the plasmid molecular clone using Tran-
sIT-LT1 as described by the manufacturer (Mirus Bio, Madi-
son, WI). Every 24 h the media were harvested and replaced 
with fresh media. After 72 h, the virus-containing media 
were clarified and then concentrated by ultracentrifugation 
(26,000 rpm for 90 min in a Beckman SW28.1 rotor) through 
a 20% sucrose cushion. After centrifugation, the media and 
sucrose were removed and the pelleted virus resuspended in 
OptiMEM (Invitrogen, Carlsbad, CA), aliquoted, and stored 
at −80 °C. Virus was quantified by p27 ELISA as described 
by the manufacturer (Beckman-Coulter, Miami, FL).
Detection of Vpx in virions
Viruses were produced in the manner described above for 
analysis of Vpx incorporation. However, after the 48 h har-
vest, the virus was clarified and pelleted through 20% su-
crose. At this time, the cells were also harvested, washed, 
and lysed with 0.5 mL M-PER solution (Pierce Biotechnol-
ogy, Rockford, IL). Protein concentrations of the cell lysates 
were determined by BCA protein assay as described by 
the manufacturer (Pierce Biotechnology). The pelleted vi-
rus was resuspended directly into 0.25 mL 1× SDS-PAGE 
sample buffer. Vpx and p27 capsid were detected by SDS-
PAGE and Western blotting as follows: Either 20 μL of pel-
leted virus or 20 μg of cellular protein per lane was sepa-
rated by SDS-PAGE, then blotted to PVDF. Western blots 
for Vpx were performed using a monoclonal anti-Vpx anti-
body (Kappes et al., 1993) followed by an HRP-conjugated 
anti-mouse secondary antibody (Amersham Biosciences, 
Piscataway, NJ) and was detected using the ECL Plus sys-
tem as described by the manufacturer (Amersham Bio-
sciences). The p27 capsid protein was detected using the 
AG3.0 anti-p24 monoclonal antibody (Simm et al., 1995) 
and an HRP-conjugated anti-mouse secondary antibody.
GFP fusion protein localization
GFP-Vpx is described elsewhere (Pancio et al., 2000). 
Mutations were introduced into GFP-Vpx by PCR over-
lap extension and confirmed by sequencing. HeLa cells 
were maintained and transfected similar to 293T cells as 
described above. The transfection, fixation, DAPI stain-
Figure 6. Prediction of helical structure in Vpx. Amino ac-
ids 23–87 of Vpx were modeled against the HIV-1 Vpr struc-
ture (Morellet et al., 2003) using Robetta/Rosetta (Kim et al., 
2004, Chivian et al., 2003, and Rohl et al., 2004). Helix 1–3 indi-
cates predicted a-helices at aa 24–37, 42–59, and 72–86, respec-
tively. The predicted region containing the NLS, aa 60–71, is in 
orange between helix 2 and 3. The figure was rendered with 
DeepView (Guex and Peitsch, 1997).
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ing, and imaging of cells were performed as previously de-
scribed (Belshan and Ratner, 2003). Images presented rep-
resent the dominant phenotype observed.
Virus infections
The MAGI-5 indicator cell line has been described else-
where (Pirounaki et al., 2000). The cells were maintained in 
DMEM supplemented with 10% fetal calf serum, 4 mM l-
glutamine, 1 mM Na-pyruvate, and 100 μg/mL penicillin/
streptomycin. To assay virus infection, MAGI-5 cells were 
seeded at 0.4 × 104 cells/well in a 96-well plate. The next 
day, the cells were infected in triplicate with 1, 5, and 25 
ng of virus in the presence of 20 μg/mL of DEAE-dextran. 
Forty-eight hours later, the cells were fixed and stained for 
the expression of β-galactosidase. The number of blue nu-
clei was counted to determine the level of infection. Results 
are presented as a percentage of the level of infection of the 
parental ROD10 and represent a total of at least three inde-
pendent experiments (therefore 9+ wells for each virus).
U937 cells were maintained in RPMI supplemented 
with 15% fetal calf serum, 4 mM l-glutamine, and 100 μg/
mL penicillin/streptomycin. For the experiments examin-
ing the infection of arrested cells, 48 h prior to infection, the 
cells were pelleted, washed, and resuspended in serum-
free RPMI (still containing l-glutamine and antibiotics) to 
arrest and synchronize the cells. Immediately prior to in-
fection, the cells were counted and resuspended at 1 × 106 
cells/mL in either complete RPMI (dividing) or complete 
RPMI containing 4 μM l-mimosine to arrest cells. 4 mL of 
cells (4 × 106) was aliquoted into one well of a 6 well plate 
for each virus, plus one additional well of dividing and 
non-dividing cells for cell-cycle analysis after the infections 
were completed. Cells were then infected with 20 μg of vi-
rus that had been treated with Turbo DNaseI (Ambion, 
Austin, TX) for 30 min at 37 °C. At 0, 24, and 48 h post-in-
fection, 1 mL of cells ( 1 × 106 cells) was removed. Cells 
were pelleted, the media removed, and the cells washed, 
and resuspended in 0.2 mL PBS. RNA-free, genomic DNA 
was isolated using the DNeasy method as described by the 
manufacturer, Qiagen (Valencia, CA). After the final time 
point, cell-cycle analysis was performed to confirm that the 
cells treated with l-mimosine were arrested using the Cy-
cleTEST PLUS DNA Reagent kit as described by the manu-
facturer (Becton Dickinson, San Jose, CA).
Nested Alu PCR
Detection of integrated proviral DNA was performed 
using a nested PCR method adapted from Brussel and So-
nigo (2003). The initial PCR used 500 nM of HIV-2 LTR 
specific primer with a linker (underlined) and two Alu re-
peat element primers to amplify a pool of products from 
the genomic DNA. The HIV-2 primer (LROD13) sequence 
was 5′-ATGCCACGTAAGCGAAACTGCGAGGCTG-
GCAGATTGAGCCCTG-3′. The first Alu primer was 5′-
TCCCAGCTACTGGGGAGGCTGAGG-3′; the second was 
5′-GCCTCCCAAAGTGCTGGGATTACAG-3′. A 20 μL vol-
ume PCR reaction was performed using a 1× JumpStart 
REDTaq reaction (Sigma, St. Louis, MO) with 4 μL of the 
genomic DNA sample as a template. After an initial 8 min 
95 °C incubation to activate the enzyme, 12 cycles of 95 
°C for 30 s, 60 °C for 30 s, and 72 °C for 3 min were per-
formed. The second PCR was performed with 2 μL of the 
initial PCR using a 1× JumpStart REDTaq reaction supple-
mented with 0.1 μCi [32P]α-TTP per 20 μL reaction. For 
this reaction, 500 nM of the linker primer (5′-ATGCCACG-
TAAGCGAAACTGC-3′) and an HIV-2 U5-specific primer 
(5′-TTACTCAGGTGAACACCGAATGACCAGGC-3′) were 
used. After an initial 8 min 95 °C incubation to activate the 
enzyme, the reaction conditions for the second PCR were 
35 cycles of 95 °C for 30 s, 60 °C for 30 s, and 72 °C for 30 s. 
This PCR resulted in the amplification of a 242 bp product. 
To visualize the products, 10 μL of each reaction was elec-
trophoresed through an 8% native TBE-polyacrylamide gel. 
After electrophoresis, the gel was dried and exposed to au-
toradiography film. Unfortunately, the nested PCR method 
combined with the [32P]TTP labeling resulted in an occa-
sional background band. It was for this reason we analyzed 
for integration at both 24 and 48 hpi. Each mutant was also 
assayed independently at least three times. The results 
present the dominant phenotype observed.
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